Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Invested Capital: 2009-2020

Historic Invested Capital for Neurocrine Biosciences (NBIX) over the last 12 years, with Dec 2020 value amounting to $1.1 billion.

  • Neurocrine Biosciences' Invested Capital rose 9.49% to $1.3 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $1.3 billion, marking a year-over-year increase of 9.49%. This contributed to the annual value of $1.1 billion for FY2020, which is 2.44% down from last year.
  • According to the latest figures from FY2020, Neurocrine Biosciences' Invested Capital is $1.1 billion, which was down 2.44% from $1.2 billion recorded in FY2019.
  • Neurocrine Biosciences' Invested Capital's 5-year high stood at $1.2 billion during FY2019, with a 5-year trough of $315.7 million in FY2016.
  • Moreover, its 3-year median value for Invested Capital was $1.1 billion (2020), whereas its average is $1.1 billion.
  • In the last 5 years, Neurocrine Biosciences' Invested Capital declined by 25.96% in 2016 and then spiked by 181.77% in 2017.
  • Yearly analysis of 5 years shows Neurocrine Biosciences' Invested Capital stood at $315.7 million in 2016, then skyrocketed by 181.77% to $889.6 million in 2017, then climbed by 12.21% to $998.3 million in 2018, then increased by 15.64% to $1.2 billion in 2019, then declined by 2.44% to $1.1 billion in 2020.